Use of Bioresorbable Vascular Scaffold technology in treating coronary bifurcation lesions: A report about long-term clinical results and review of available literature | Zendy

Wael Elabbassi | Zendy; Muhammad Abdul Baker Chowdhury | Zendy; Róbert Hatala | Zendy

Open Access

Use of Bioresorbable Vascular Scaffold technology in treating coronary bifurcation lesions: A report about long-term clinical results and review of available literature

Author(s) -

Wael Elabbassi,

Muhammad Abdul Baker Chowdhury,

Róbert Hatala

Publication year - 2019

Publication title -

bratislavské lekárske listy/bratislava medical journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.387

H-Index - 32

eISSN - 1336-0345

pISSN - 0006-9248

DOI - 10.4149/bll_2019_088

Subject(s) - mace , medicine , restenosis , cardiology , diabetes mellitus , conventional pci , percutaneous coronary intervention , stent , surgery , myocardial infarction , endocrinology

BVS proved safe in humans. ABSORB trials showed them performing similar to Drug Eluting Stents in simple coronary interventions. We assessed a registry of 63 patients with bifurcation lesions, treated by BVS and followed their outcomes up-to 5 years.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research